Inogen (Nasdaq:INGN) this week posted third-quarter results that beat the overall consensus on Wall Street. The Goleta, California-based respiratory care company reported a loss of $9.5 million, or -42¢ per share, on sales of $105.4 million for the three months ended Sept. 30, for a sales growth of 13.19% compared with Q3 2021. Adjusted to […]
Inogen
Inogen posts Street-beating Q2
Inogen (Nasdaq:INGN) shares are down today — a day after releasing Q2 results that beat the consensus forecast. The Goleta, California–based respiratory care company posted losses of $3.4 million, or 15¢ per share, on sales of $103.4 million for the three months ended June 30, 2022, for a bottom-line slide into the red on sales […]
Inogen appoints Agnes Lee as senior VP of investor relations, strategic planning
Inogen (NSDQ:INGN) this week announced it appointed Agnes Lee as senior VP of investor relations and strategic planning, effective May 23. Lee most recently served as VP of investor relations at Butterfly Network where she created an investor relations program to promote the company to analysts and investors. She also led investor marketing to reflect […]
Inogen rises despite missed Q4 projections
Inogen (NSDQ:INGN) shares ticked up today on fourth-quarter results that came up shy of the consensus forecast. INGN shares were up 6.9% at $32.01 per share in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1.1%. The Goleta, California-based maker of home […]
Inogen CFO stepping down, interim replacement named
Inogen (NSDQ:INGN) announced today that it appointed Mike Sergesketter as its interim chief financial officer. Goleta, California–based Inogen said in a news release that Sergesketter — whose role as CFO was made effective today — most recently served as CFO of Kimball Electronics. Sergesketter succeeds Alison Bauerlein, who will remain with the portable oxygen therapy […]
Inogen names chief technology officer
Inogen (NSDQ:INGN) this week announced that it has appointed Stanislav Glezer as chief technology officer. Glezer will be responsible for R&D and engineering, medical affairs and regulatory affairs. He joined the company in June this year as chief medical officer and will remain an EVP at the company. Prior to joining the company, Glezer held numerous […]
MedTech 100 roundup: Significant uptick for industry
The up-and-down nature of the medtech industry continues to carry through 2021, with a recent dip now followed by a rapid ascent. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 11) at 109.63 points, producing a 2.5% rise from the 106.96-point mark set one […]
Inogen appoints BD veteran as chief medical officer
Inogen (NSDQ:INGN) this week announced that it has appointed Dr. Stanislav Glezer as EVP and chief medical officer, effective June 21. Glezer joins the Goleta, Calif.–based oxygen therapy technology company after a stint as worldwide VP of medical affairs for diabetes care at BD. Prior to BD, he served as chief medical officer at Adocia […]
Inogen beats Wall Street EPS consensus by 22¢ in Q1 results
Inogen (NSDQ:INGN) posted first-quarter results yesterday that beat the overall consensus on Wall Street. The Goleta, Calif.-based company reported losses of -$732,000, or -3¢ per share, on sales of $86.932 million for the three months ended March 31, for a sales loss of -1.76% compared with Q1 2020. Earnings per share were -3¢, 22¢ ahead of […]
Inogen names former BD exec as chief commercial officer
Inogen (NSDQ:INGN) announced today that its board of directors appointed George Parr as its EVP and chief commercial officer. Goleta, Calif.–based Inogen’s EVP of marketing, Byron Myers, and EVP of sales, Arron Retterer, announced earlier this month that they plan to leave the portable oxygen therapy company, effective June 4, 2021, following a transition period. […]
Inogen names new CEO
Inogen (NSDQ:INGN) announced that it appointed Nabil Shabshab to serve as its new CEO, effective on Feb. 8, 2021. Additionally, according to a news release, on Jan. 22, Inogen’s board appointed Shabshab to serve as a Class II director of the company, effective Feb. 8, too. His term will expire at the annual meeting of stockholders […]
